Avantor (NYSE:AVTR) Director Purchases $1,001,250.00 in Stock

Avantor, Inc. (NYSE:AVTR) Director Sanjeev Mehra acquired 125,000 shares of the business’s stock in a transaction dated Tuesday, March 10th. The stock was purchased at an average cost of $8.01 per share, for a total transaction of $1,001,250.00. Following the transaction, the director owned 475,000 shares in the company, valued at approximately $3,804,750. The trade was a 35.71% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Avantor Stock Up 2.1%

Shares of NYSE AVTR traded up $0.17 during trading hours on Wednesday, hitting $8.32. 9,661,164 shares of the stock were exchanged, compared to its average volume of 12,524,850. Avantor, Inc. has a 12 month low of $7.82 and a 12 month high of $17.11. The firm has a fifty day moving average price of $10.57 and a 200-day moving average price of $11.77. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. The company has a market cap of $5.68 billion, a PE ratio of -10.67, a PEG ratio of 3.20 and a beta of 0.97.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.01. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The company had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period last year, the firm earned $0.27 earnings per share. Avantor’s revenue was down 1.4% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. On average, sell-side analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.

Hedge Funds Weigh In On Avantor

Hedge funds have recently made changes to their positions in the company. EverSource Wealth Advisors LLC raised its stake in Avantor by 119.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after acquiring an additional 1,189 shares during the last quarter. Strategic Wealth Investment Group LLC purchased a new stake in Avantor during the 2nd quarter valued at about $32,000. Private Trust Co. NA grew its stake in Avantor by 46.2% during the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after purchasing an additional 875 shares during the last quarter. Osaic Holdings Inc. increased its holdings in shares of Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after purchasing an additional 1,064 shares during the period. Finally, Los Angeles Capital Management LLC acquired a new position in shares of Avantor in the fourth quarter valued at about $32,000. 95.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on AVTR. Barclays reissued an “underweight” rating and issued a $8.50 price objective on shares of Avantor in a research report on Friday, March 6th. TD Cowen reiterated a “hold” rating on shares of Avantor in a research note on Thursday, February 12th. Citigroup lowered their price target on Avantor from $13.00 to $11.00 and set a “neutral” rating for the company in a report on Thursday, February 12th. Wells Fargo & Company dropped their price target on Avantor from $16.00 to $14.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. Finally, Robert W. Baird set a $11.00 price objective on shares of Avantor in a report on Thursday, February 12th. Three research analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $11.80.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.